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Purpose: Establish the efﬁcacy of posterior tibial nerve stimulation in treating faecal incontinence
associated to sphincter defect.
Methods: Prospective study that included patients with faecal incontinence associated to sphincter le-
sions between 90 and 180. Clinical anamnesis, physical examination, reverse visual analogic scale, in-
continence diary and Wexner score were recorded at baseline and 6 months. Anal manometry was
realized at baseline and 6 months.
Subjects underwent one 30-min session every week for 12 consecutive weeks and was continued with 6
additional sessions every 2 weeks.
Results: Sixteen patients were analysed, 15 women and 1 men, with a mean age of 56.5 years. The in-
continence were obstetric origin (50%) and perineal surgeries (50%). Four patients who did not continue
with the second stage.
Referring to the retention time, at baseline 12 patients (75%) did not bear even 1 min. At 6 months the
retention time was <1 min in only 2 patients (p ¼ 0.008).
Median Wexner baseline values were 10; at 6 months decrease to 5 (p ¼ 0.006). The visual analogical
scale (VAS) increased from 6 to 7.5 (p > 0.05). After 6 months, maximum resting pressure increased from
40.9 to 51 mmHg (p < 0.001) and maximum squeeze pressure from 82.5 to 94 mmHg (p < 0.001).
Conclusion: PTNS is an effective treatment for faecal incontinence associated to sphincter lesions because
the number of incontinence episodes per week, the Wexner Score, the ability to defer defaecation and
the manometric determinations improved signiﬁcantly.
 2013 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
Faecal incontinence (FI) is a prevalent and important condition,
with a wide range of treatment options. An anal sphincter lesion
(ASL) is the most common cause of faecal incontinence.1,2 In these
cases with ASL, when conservative therapy that include dietary
modiﬁcation, constipating medications, suppositories, physio-
therapy/pelvic ﬂoor exercises and biofeedback has failed, the
traditional surgical approach to this disabling condition is sphinctere, Department of Surgery, C/
Spain. Tel.: þ34 966679377;
).
Elsevier Ltd on behalf of Surgicalrepair. However, long-term follow-up has shown that initial success
tends to worsen over time with the reappearance of FI symptoms
and decrease of satisfaction in approximately half the patients.3,4
Recently, sacral nerve stimulation (SNS) has been proposed as an
effective therapeutic option for FI in patients with an anal sphincter
lesion. However, SNS therapy has a high cost, requires an operating
theatre and carries with it the risk of potentially signiﬁcant com-
plications.5e7
For this reason, posterior tibial nerve stimulation (PTNS) has
been started using as an alternative or the ﬁrst step before the
utilization of the SNS. As it happened initially with the use of SNS,
PTNS has been used only for FI associated with a neurogenic lesion
or idiopathic, and evidence of trauma of the external anal sphincter
(EAS) was an exclusion criterion.8Associates Ltd.
Table 1
Faecal incontinence antecedents.
Diabetes mellitus 18.8%
Radicular pathology 18.8%
Arterial hypertension 18.8%
Haemorrhoidectomy 18.8%
Anal ﬁstulae 25%
Anal ﬁssure 31.3%
Pelvic surgery 42.1%
Episiotomy 35.5%
Multiparous 56.3%
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tients with ASL has not been reported and could be a good option.
The aim of this prospective study was to establish further the ef-
ﬁcacy of PTNS in treating faecal incontinence associated to
sphincter defect.
2. Methods
We performed a prospective interventional study. Patients with
faecal incontinence of diverse causes, who were refractory to
medical treatments, were included in the study. We selected pa-
tients that endoanal ultrasonography showed sphincter lesions
between 90 and 180. Exclusion criteria included inability to
communicate (e.g., patients with Alzheimer’s disease, among
others), acute anatomical problems with possible surgical resolu-
tion (less than 3 months) and unwillingness to consent to partici-
pating in the study. Gravity stages or Wexner scale degrees were
not considered exclusion criteria.
The patients were evaluated by surgeons who were members of
the coloproctology unit at the General University Hospital of Elche
and Reina Soﬁa Hospital of Murcia. The patients were interviewed
and underwent a physical examination (examination of the anal
canal, determination of weakness of the sphincter, scars or over-
view features). Complementary tests included anal manometry and
anal ultrasonography. We determined the Wexner scale. According
to the data obtained from the incontinence diary, the patients were
divided into the following three groups: patients with fewer than 3
episodes of faecal incontinence per week (mild), patients with 3
and 7 episodes per week (moderate) and patients with more than 7
episodes per week (severe). Their perception of the degree of in-
continence was quantiﬁed with a visual analogic scale (VAS). A
reverse scale was used, with 0 being the worst and 10 the best.
After determining the initial diagnosis, the ﬁrst 12 sessions of
the percutaneous tibial neurostimulation (PTNS process were per-
formed weekly and the next 12 every 2 weeks.
2.1. Manometry
Anorectal manometry was performed with a device from Albyn
medical, Palex, with 8 channels and a poly-isoprene balloon, which
was 4.9 mm in diameter (Serial MS4 1401, Ross-Shire, Escocia). The
transductor was placed across the anal canal into the rectum.
Manometric measures included sphincter pressures at rest and
during squeeze time and at different distances from the anal canal.
A low resting pressure of the anal canal was used as the baseline
measure for relaxation and tonic activities of both internal anal
sphincter (IAS) and external anal sphincter (EAS). Squeeze pressure
was measured while asking the patient to contract the EAS. We
determined the tonic activities during relaxation (resting) and
contraction (squeeze) at 6, 5, 4, 3, 2 and 1 cm from the anal border
to identify the sphincter. The values were measured in millimetres
of mercury (mmHg). The same tests were repeated after 6 months
of treatment.
2.2. Anal ultrasonography
A high-frequency panoramic ultrasound scan within the anal
canal was performed using the Pro Focus, Ultrasound Scanner Class
I, Type B. Ref: 2002 SN1880355, BK Medical, model. Herlev,
Dinamarca.
2.3. Posterior tibial nerve stimulation (PTNS)
The PTNSwas performed by surgeonswhoweremembers of the
coloproctology unit at the General University Hospital of Elche andReina Soﬁa Hospital of Murcia. The urgent PC 200 Neuromodulation
System (Uroplasty, Minnetonka, MN, USA) was used. Subjects
underwent one 30 min session every week for 12 consecutive
weeks. Afterwards, we compared the values before and after
treatment and repeated the treatment for an additional 6 sessions
every 2 weeks in all patients that had shown any clinical im-
provements after the ﬁrst stage.
Subjects were placed in the supine position without anaes-
thesia. PTNS was delivered using a needle electrode that was
inserted 3e4 cm cephalad and 2 cm posterior to the medial mal-
leolus at a 60 angle towards the ankle joint to a depth of
approximately 0.5e1 cm. Successful placement was conﬁrmed by
the presence of electric sensation 5 cm above and below the
insertion site or a digital plantar ﬂexion. PTNS was undertaken at
the highest ampliﬁcation (0e20 mA) at a frequency of 20 Hz
causing neither a motor response nor pain.2.4. Variables
Data from clinical anamnesis, the physical examination, incon-
tinence diary, VAS andWexner score were recorded at baseline and
after 3 and 6 months. Anal manometry was realized at baseline and
6 months.2.5. Statistical analysis
Statistical analysis was performed using SPSS software v.17.0
(SPSS, Chicago, IL, USA). We used Student’s t-test and ANOVA to
compare paired variables (when following a Gaussian distribution)
and ManneWhitney and Kruskal Wallis tests for variables without
a normal distribution. The chi-square test was used to compare
discrete variables. Pearson’s correlation test was used to compare
quantitative variables. A P-value <0.05 was considered signiﬁcant.3. Results
Sixteen patients were analysed, 15 women and 1 men, with a
mean age of 56.5  10.9 years. The incontinence causes can be
summarized in obstetric origin (50%) and secondary to perineal
surgeries (50%). Faecal incontinence antecedents are described in
Table 1.
The time between the initiation of the symptomatic inconti-
nence and the moment of ﬁrst medical visit before the ﬁrst year
was only 18.75% (3 patients) (Table 2). More than 60% (10 patients)
have waited over 10 symptomatic years. Associated symptoms to
faecal incontinence were sexual dysfunction in 4 patients (25%),
urinary incontinence in 2 (12.5%) and perineal pain in 2 (12.5%).
At the beginning of the study, median values of visual analogical
scale (VAS) were 6 (Range:0e8), and Wexner scale degree was 10
(Range: 3e19).
The defecator diary showed 50% of the patient with fewer than 3
episodes of faecal incontinence per week (mild), 43.8% with 3e7
Table 2
Clinical and manometric results before and after treatment.
Baseline 6 months p
Maximum resting pressure 40.9 51 0.001
Maximum squeeze pressure 82.5 94 0.001
Wexner score 10 5 0.006
Retention time 2 4 0.008
Visual analogical scale (VAS) 6 7.5 0.001
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isodes per week (severe).
Finally, the 75% of the patients had not any possibility of pro-
longing the retention time more than 1 min.
Four patients discontinued therapy by choice not because of
clinical impairment.
3.1. Manometric determinations
Baseline manometric determinations were: maximum resting
pressure (MRP) of 40.9  26.2 mmHg, and maximum squeeze
pressure (MSP) 82.5  34.6 mmHg. After 6 months, MRP increased
to 51  31.2 mmHg (p < 0.001) and MSP to 94  52 mmHg
(p < 0.001).
3.2. Delay capability
Referring to the retention time, at baseline 12 patients (75%) did
not bear even 1 min. At 6 months the retention time was <1 min in
2 patients, between 1 and 5 min in 3 patients, and >5 min in 7
patients (p ¼ 0.008).
3.3. Wexner scale
Median baseline values were 10. At 6 months, median Wexner
values decrease to 5 (p ¼ 0.006).
The visual analogical scale (VAS) increased from 6 to 7.5, but
statistical signiﬁcance was not achieved.
4. Discussion
PTNS is a recently appeared therapy for the treatment of FI. A
meta-analysis conducted by Thomas et al., in 2012 showed an
improvement of 63e82% of the episodes of incontinence, improve
of theWexner scale and an improvement of the urgency symptoms
in a total of 273 patients included. However, these studies are not
comparable between them, because methodology of PTNS and
evaluation systems were different in each group. Moreover, this
studies also excludes patients with sphincter injury as from the
start of therapy has been questioned as an exclusion criterion, or at
least don’t identify patients with sphincter injury.8
In our knowledge, our study is the ﬁrst one that analysed the
efﬁcacy of PTNS in treating faecal incontinence associated to large
sphincter defect. Our results suggests that PTNS is an effective
treatment for FI in the presence of an ASL as shown on anal ultra-
sound because the number of incontinence episodes per week, the
Wexner Score, the ability to defer defaecation and the manometric
determinations improved signiﬁcantly.
Hotouras et al. published a study of 88 patients of whom 37 had
sphincter injury. They observed that patients with damaged anal
sphincter complex had a higher mean incontinence score than
those with intact sphincter complex prior to neuromodulation.
PTNS resulted in improved incontinence scores, deferment time
and weekly incontinence episodes for both groups of patients
regardless of sphincter integrity. However, the methodology of thisstudy is not deﬁned classiﬁcation of sphincter injury grades and
damaged sphincter complex.9
The action mechanism of PTNS is still not completely under-
stood. Stimulation of somatic afferents modulating visceral func-
tions is most likely the main underlying neurophysiological
mechanism. PTNS trigger a spinal and supraspinal somatovisceral
reﬂex activating the sympathetic nervous outﬂowwith inhibition of
colorectoanal motility, increasing internal sphincter tone and rectal
compliance, and also interfering with the rectal sensory thresholds
for defecation.10 It is hypothesized to access, indirectly, the same
sacral nerve roots targeted in sacral nerve stimulation via the pos-
terior tibial nerve, containing sensorimotor and autonomic ﬁbres
derived from the 4th and 5th lumbar and 1st to 3rd sacral roots.
Moreover it is uncertain how PTNS works in patients with ASL.
Faecal incontinence is not merely due to the sphincter disruption.
Although defects after childbirth are related to faecal incontinence,
traction and damage to the pudendal nerve and rectal sensory and
motordysfunction are also contributing factors. Treatment of in-
continence is also multi-factorial and is not solely based on
repairing the sphincter defect. This is supported by the fact that
therapies such as biofeedback or pudendal nerve stimulation or
SNS or PTNS, in the present study, can improve faecal incontinence
in patients with ultrasound evidence of a sphincter defect.
On the other hand, PTLN has advantages in cost, simplicity of the
procedure, risk of potentially signiﬁcant complications, not requires
hospitalization or operating theatre, compared to SNS.
According to a recent study conducted by Leroi et al.11 on SNS,
the calculated costs for the “test procedure,” including care and
operation time, amounted to 4000 V. The material costs for the
permanent implantation procedure with the inclusion of hospital
costs were 16.000 V. Taking into account costs at subsequent
outpatient visits, the total cost for a patient having a permanent
implant amounts to approx. 21.500 V. In comparison, the costs
reported for PTNS are considerably less. The hospital and doctor
costs for a 20- to 30-min session amount to about 25 V. For a pa-
tient needing treatment with 10 weekly sessions and then 5
monthly sessions, the total costs would be about 400 V.12 Even
some groups are working on the possibility that these treatments
can be performed in the outpatient clinic by an adequately trained
nurse or physiotherapist, and the effects can be maintained by the
patients at home, which reduce costs and are convenient for both
patients and healthcare providers.13,14
Sacral nerve stimulation (SNS) achieves complete continence in
41e75% of patients, with at least a 50% reduction in incontinence in
75e100%. However, in addition to undergoing an anaesthetic and
invasive procedure, adverse events are seen in 12.8%, some of
which (such as device infection and lead migration) mandate
replacement or re-implantation in 6.7%. Furthermore, after
approximately 8 years, device batteries must be replaced.5e7,15 By
contrast, awealth of evidence supports the efﬁcacy, safety and cost-
effectiveness of PTNS in treating urinary and faecal incontinence.
Technically simple to perform, there is no requirement for anaes-
thesia or insertion in the operating theatre.16
Similar stimulation may be possible with the use of pudendal
nerve stimulator. The pudendal nerve supplies skin, organs and
muscles of the perineum so is concerned with micturition,
defaecation, clitoral erection and parturition. Improvement in the
function of the pudendal nerve therefore should lead to
improved anorectal physiologic parameters and reduction in
symptoms for patients with faecal incontinence, particularly if its
aetiology is perineal trauma or dysfunction leading to reduced
anal tone. This pudendal nerve stimulator has advantages over
similar devices in that it can be applied externally to the base of
the clitoris or penis allowing easy application and removal. Fri-
zelle et al.17 showed a signiﬁcant reduction in incontinence
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42 patients treated and was accompanied by signiﬁcant im-
provements in anal sphincter tone, maximal tolerated rectal
volume and the sustained rectoanal inhibitory reﬂex.
Our treatment strategy for patients with faecal incontinence and
an anal sphincter defect has changed as a result of the present
study. After the failure of hygienic-dietary measures and biofeed-
back, we now start with a PTNS regardless of the morphological
state of the anal sphincter complex. If this therapy fails, we proceed
to asses SNS or surgery.
However, we need randomized clinical trials to prove if PTNS is
the ﬁrst best option and an effective treatment for faecal inconti-
nence in the presence of an anal sphincter defect.
5. Conclusion
PTNS is an effective treatment for faecal incontinence in the
presence of an anal sphincter defect because the number of in-
continence episodes per week, the Wexner Score, the ability to
defer defaecation and the manometric determinations improved
signiﬁcantly.
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